Children's National Hospital
111 Michigan Ave NWWashington, DC 20010
Andrew Campbell, M.D., is the director of the Comprehensive Sickle Cell Disease Program at Children's National Hospital. His research interests span several topics in sickle cell disease including pulmonary complications, fetal hemoglobin switching in transgenic sickle cell mice, phenotype/genotype relationships and renal complications.
| University | Degree | Focus | Graduated |
|---|---|---|---|
| Case Western Reserve University School of Medicine | Medical Degree | 1996 | |
| University of Mi Medical Sch | Other Degree | 2012 |
| Institution | Focus | Year |
|---|---|---|
| Residency - Massachusetts General Hospital | 1999 | |
| Fellowship - Pediatric Hematology/Oncology, Children's Memorial Hospital | 2002 |
| Certification | Cert. Body | Year |
|---|---|---|
| Pediatrics Sub-Specialty: Pediatric Hematology-Oncology | Dermatology | Not Specified |
| Role | Organization | Time |
|---|---|---|
| Member | National Medical Association | Present |
| Member | Children's Oncology Group | Present |
| Member | American Academy of Pediatrics | Present |
| Member | American Society of Hematology | Present |
| Member | Ernest E. Just Society | Present |
| Member | Medical Student Section, American Medical Association | Present |
| Member | Morehouse College Alumni Association | Present |
| Member | Phi Beta Kappa Honor Society | Present |
Accepts New Patients: Yes
Andrew Campbell, MD has not yet listed the medications that he commonly prescribes.
Andrew Campbell, MD has not yet specified the insurance plans he accepts.